HIVAging
Meeting category
Date(s)
23 Sep 2021 - 24 Sep 2021
Important dates
Late Fee Registration Deadline
22 September 2021 at 23:59 EDT
Meeting type
Virtual Meeting
CME credits
5
Organizer

International Workshop on HIV & Aging 2021

Related Enduring Materials

Enduring Materials

Thursday, 23 September 2021

Session 1: Immune Senescence in Elderly PLWH - 10:05
10:05 EDT
Plenary Lecture: Role of Immunosenescent Cells in the Aging Process
Darren Baker, PhD, MS
Mayo Clinic Graduate School of Biomedical Sciences, Minnesota, United States
10:25 EDT
Biological Mechanism/ Inflammation, Thrombosis & COVID
Russell Tracy, PhD
University of Vermont (UVM), United States
10:35 EDT
COVID Vaccine Effectivity in Aging Population / Immune Protection
George Kuchel, MD, FRCP, AGSF
University of Connecticut Center on Aging, United States
10:45 EDT
COVID-19 Vaccines, HIV, and Aging
Kathryn Stephenson, MD, MPH
Harvard Medical School / Ragon Institute / Beth Israel Deaconess Medical Center, United States
Abstract Session - 11:40
11:40 EDT
Abstract-Driven Presentations
High HIV Viral Load is Associated with Incident Venous Thromboembolism
#1 Stephanie Ruderman, MPH, University of Washington, United States
Skeletal muscle: a critical organ for successful aging in people living with HIV?
#2 Brendan Payne, MD PhD, Newcastle University, United Kingdom
High-dimensional polychromatic flow cytometry reveals mucosal-homing as a putative biomarker of natural killer cells in persons aging with or without HIV
#3 R. Keith Reeves, PhD, Duke University, United States
Undertreated midlife symptoms for women living with HIV linked to lack of menopause discussions with providers
#4 Elizabeth King, MD, Infectious Diseases, Canada
Black/African American and Hispanic Older Women Living with HIV: Factors Related to their HIV Psychosocial Impact
#5 Evelyn Iriarte, University of Miami, United States
Polypharmacy and cognitive function in older women with and without HIV
#6 Leah Rubin, PhD, MPH, Johns Hopkins University, United States
Non-Communicable Diseases in Older Persons Living with and without HIV in Four African Countries
#7 David Chang, MD, Walter Reed Army Institute of Research, United States
"A telephone-based multidimensional interview in elderly people living with HIV from the GEPPO cohort "
#8 Micol Ferrara, Ospedale Amedeo Di Savoia, Italy
Lightning Poster Session - 12:45
12:45 EDT
Lightning Poster Presentations
David Moore, PhD
University of California – San Diego, United States
Trends of polypharmacy and 2DR antiretroviral use: a 15-year observational matched-cohort study
#11 Jovana Milić, MD, University of Modena and Reggio Emilia, Italy
Adherence to antiretroviral therapy among older people living with HIV and geriatric conditions
#12 Brianne Olivieri-Mui, PhD, The Marcus Institute for Aging Research, United States
Burden of age-associated chronic comorbidities among people living with and without HIV: Years of life lost to premature mortality in British Columbia, Canada
#13 Ni Gusti Ayu Nanditha, BSc, BC Centre for Excellence in HIV/AIDS, Canada
Integration of ASCVD risk score in HIV geriatric care model: The STRONG Study
#14 Jennifer Hoffmann, MPH, CRNP, University of Maryland, United States
Elevated Hepatic Steatosis Index is Associated with Greater Frailty, ASCVD risk score, and Fat Mass Index in Older Adults with HIV
#15 Carrie Johnston, MD, NYP-Weill Cornell Medical Center, United States
Relationships Between Frailty, Physical Function, and NAFLD
#16 Paula Debroy, MD, University Of Texas, United States
Transitions in frailty phenotype states and its association with frailty index: A multi-state Markov model study
#17 Jovana Milić, MD, University of Modena and Reggio Emilia, Italy
Comparative Prevalence of Premature Cognitive Aging in Adult Ugandans Living with HIV and demographically matched HIV-negative controls
#18 Amara Ezeamama, Michigan State University, United States
Informal "Lobby Discussions" on Zoom -
Moderator
Jules Levin, MS
National AIDS Treatment Advocacy Project, United States

Friday, 24 September 2021

Session 2: Factors Impacting Quality of Life - Aging PLWH - Loneliness - 10:10
10:10 EDT
Aging, Coping, and Living with HIV in the Context of Oppression
Sannisha Dale, PhD, EdM
University of Miami, United States
10:20 EDT
Cognitive Impairment in Aging PLWH
10:30 EDT
Neurologic Complications of COVID-19
Scott Letendre, MD
University of California – San Diego, United States
10:45 EDT
Abstract-Driven Presentations
Factors influencing psychological distress during the COVID-19 pandemic in people aging with HIV.
#9 Marie-Josée Brouillette, MD, McGill University Health Centre, Canada
The Utility of Hearing Assessments in Identifying Amnestic Mild Cognitive Impairment among People with HIV: A Pilot Study
#10 Erin Sundermann, PhD, HIV Neurobehavioral Research Program, University Of California, San Diego, United States
10:55 EDT
Panel Discussion (Including Community Perspective)
David Moore, PhD
University of California – San Diego, United States
Session 3 - 11:40
11:40 EDT
Lung Disease & HIV (aging)
Gregory Kirk, MD, MPH, PhD
Johns Hopkins University, United States
11:55 EDT
Effect of Sleep Deprivation
Ken Kunisaki, MD, MS
University of Minnesota, United States
Session 4: Delivery of Care for Elderly PLWH - 12:25
12:25 EDT
Introduction
Julian Falutz, MD, FRCPC
McGill University, Canada
12:30 EDT
Telehealth in Clinical Settings / Transition (since COVID)
Alan Winston, MBChB, FRCP, MD
Imperial College, United Kingdom
12:40 EDT
Frailty and Resilience in People Living with HIV during the COVID Era: Two Complementary Constructs?
Giovanni Guaraldi, MD
University of Modena and Reggio Emilia, Italy
Informal "Lobby discussions" on Zoom -
Moderator
Jules Levin, MS
National AIDS Treatment Advocacy Project, United States
Overview
Image
HIV Aging
Welcome

The International Workshop on HIV & Aging was held virtually on 23-24 September 2021. The mission of this Workshop was to provide a unique and much-needed platform to integrate the disparate fields of geriatrics, internal medicine, HIV biology, pharmacology, psychology, and numerous medical subspecialties in an interactive and focused setting that presents and discusses the latest biological knowledge and strategies that may improve the future of persons aging with HIV. With the dramatically extended life expectancy of those living with HIV due to effective antiretroviral therapy (ART), this mission becomes more vital with each passing year. 

People receiving ART rarely die from AIDS, but in comparison to similar HIV-negative populations, they may experience an excess of morbidity and mortality including a relatively early onset of aging complications such as neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls. It is a very high priority to understand the interaction between age and HIV infection that accounts for this clinical picture. To this end, the Workshop had an intimate size and multidisciplinary program intended promote professional interactions, which have led to many long-lasting and productive collaborations. The Workshop also prioritized opportunities for trainees and junior investigators to present their research, network, and learn from experts in the field.

This year, we are excited that the Workshop included a highly diverse team of basic and clinical scientists, clinicians, trainees, and community members. The program delved into basic science (for example, immunosenescence and inflammation in aging) and clinical challenges (for example, neurological and mental health impairments, remote delivery of health care, and approaches to frailty). Hot topics included a variety of speaker and panels covering the effects and clinical consequences of COVID-19 infection on aging with HIV. Through abstract presentations and organized discussions of the oral and poster presentations, the 12th workshop was stimulating and successful. 

To stay updated on our upcoming programs, make sure you are signed up for our newsletter.

Chairs
Unique Features
• Two-day virtual meeting
• Invited lectures from international experts
• Interactive round-table discussions
• Ample time for discussion
Who Should Attend?
Internal Medicine specialists (clinicians working in cardiovascular, renal, endocrine, and metabolic complications of HIV areas), infectious disease specialists, (virologists, immunologists, pharmacologists), geriatricians, neurologists, epidemiologists, geneticists and other clinical researchers; community advocates, industry representatives.
Meeting Objectives
The Meeting Objectives for this workshop are to:

- Facilitate an unbiased and scientific knowledge exchange regarding HIV and aging, and encouraging early career investigators to actively partake in the workshop;

- Summarize and promote the current state of the science regarding HIV and aging and its successful translation and dissemination;

- Foster new and lasting cross-disciplinary partnerships and collaborations.
Learning Objectives
After attending this workshop, participants will be able to:

- Identify age-related clinical complications found in older people living with HIV;

- Integrate the latest scientific research into daily clinical care to improve the quality of life of these people;

- Identify the future challenges faced by this expanding population of older people living with HIV.

Practical Information 

Certificate of Attendance
A certificate of attendance will be sent to participants after the have attended the workshop and completed the post-meeting survey.
Language
The official language of the workshop is English. Translation will not be provided.
Meeting Portal
The link to access the workshop will be shared closer to the start date.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Media Representation
For rates and conditions, please visit the registration page of this workshop.
Support
Platinum Level Sponsor
Silver Level Sponsor
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in research and clinical management of people aging with HIV.

This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Goda Adomonis at goda.adomonis@amededu.com or call +31 6 23711504.

Benefits of Support

By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgment on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag

*Subject to the support level

Committees

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts. 

Organizing Committee
Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Dorcas Baker, RN, BSN, ACRN, MA, Johns Hopkins University School of Nursing, MidAtlantic AIDS Education and Training Center (AETC), United States
  • Bruce Brew, MD, St Vincent's Hospital, Australia
  • Marie-Josée Brouillette, MD, McGill University Health Centre, Canada
  • Simon Collins, HIV i-Base, United Kingdom
  • Daniel Duprez, MD, University of Minnesota (Cardiology), United States
  • Meredith  Greene, MD, UCSF, United States
  • Giovanni Guaraldi, MD, Policlinico Modena, Italy
  • Marcia McDonnell  Holstad, PhD, Emory University, United States
  • Jordan  Lake, MD, MSc, UTHealth, United States
  • Alan Landay, PhD, Rush University Medical Center, United States
  • Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
  • Eugènia Negredo, MD, PhD, Universitat Autònoma de Barcelona , Spain
  • Kelly O'Brien, PhD, BScPT, BSc, University of Toronto, Department of Physical Therapy, Canada
  • Brendan Payne, PhD, Newcastle University, United Kingdom
  • Molly Perkins, PhD, Emory University School of Medicine, United States
  • Matilde Sanchez Conde, MD, PhD, Hospital Ramón y Cajal, Spain
  • Eugenia Siegler, MD, Weill Cornell Medicine, United States
  • Jeff Taylor, HIV + Aging Research Project - Palm Springs, United States
  • Phyllis Tien, MD, MSc, University of California, San Francisco, United States
  • Cara Wilson, MD, University of Colorado, United States
Industry LIaison Board

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

  • Andrew Clark, MD, ViiV Healthcare, United Kingdom
  • Richard Haubrich, MD, Gilead Sciences, United States
  • Christian Marsolais, PhD, Theratechnologies, Canada

Endorsers
Accreditation
Accreditation Statement

The International Workshop on HIV & Aging 2021, Utrecht (Livestream), Netherlands, 23/09/2021-24/09/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”

Summary Day 1 by A. Landay